Devon Kennard

Linebacker

Age: 31
Free Agency: 2023 (Void)
Accrued Seasons: 8
  • 2022 Salary Cap Charge: $3,567,794 (1.72% of cap)
  • 2022 Cash Payout: $1,500,000 (0.66% of spending)
  • 2022 Cash to Cap Ratio: 0.42
  • Contract Value: $1,500,000 ($1,500,000 APY)
  • Fully Guaranteed Money: $600,000
  • Contract Ranking: 66/263 at LB

Current Contract

(Other, signed 2022)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202231$1,120,000$2,112,500$380,000$600,000$3,567,7941.7%
2023 📝
February 10: Contract voids
32Void$2,112,500VoidVoid$2,112,5000.9%
Total$1,120,000$4,225,000$380,000$600,000$5,680,294

Contract Notes

Devon Kennard signed a three year, $20 million contract with the Cardinals. $10 million is guaranteed including a $5 million signing bonus.

Cash Flows

- fully earned money
- unearned or partially earned money
$1.5M
2022
Cash Due$1,500,000
Running Cash$1,500,000
Career Earnings: $28,773,123
Career APY: $3,596,640
Potential Earnings: $30,273,123
Total Guarantees: $18,244,560
Largest Cash Payment: $8,076,563 (2018)
Largest Cap Number: $6,157,353 (2021)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
GiantsDraftedExpired20144$2,364,560$591,140$144,560$3,471,560146.8%$867,890
LionsUFATerminated20183$17,250,000$5,750,000$7,500,000$12,301,56371.3%$6,150,782
CardinalsSFARenegotiated20204$20,000,000$6,666,667$10,000,000$13,000,00065.0%$6,500,000
CardinalsOtherActive20221$1,500,000$1,500,000$600,000$00.0%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Giants4$3,471,560$867,890$3,471,5600.0%$00.0%
Lions2$12,301,563$6,150,782$10,285,9380.0%$1,750,0000.0%
Cardinals2$13,000,000$6,500,000$8,657,3530.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusWorkout BonusOther BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2014Giants$420,000$36,140$0$0$0$0$456,1400.3%$564,560
2015Giants$510,000$36,140$0$0$0$0$546,1400.4%$510,000
2016Giants$600,000$36,140$0$0$0$0$636,1400.4%$600,000
2017Giants$1,797,000$36,140$0$0$0$0$1,833,1401.1%$1,797,000
2018Lions$2,250,000$1,750,000$250,000$100,000$0$2,250,000$4,334,3752.4%$8,076,563
2019Lions$3,500,000$1,750,000$375,000$100,000$250,000$0$5,951,5633.1%$4,225,000
2020Cardinals$1,000,000$1,250,000$250,000$0$0$1,000,000$2,500,0001.3%$6,250,000
2021Cardinals$3,662,500$2,112,500$500,000$0$0$537,500$6,157,3533.2%$6,750,000
2022Cardinals$1,120,000$2,112,500$380,000$0$0$600,000$3,567,7941.7%$1,500,000
2023Cardinals$0$2,112,500$0$0$0$0$2,112,5000.9%$0
Total$14,859,500$11,232,060$1,755,000$200,000$250,000$4,387,500$28,095,145$30,273,123
Dead Money History
TeamYearCap ChargeCash Paid
Lions2020$1,750,000$0
Total$1,750,000$0

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
2014124031.4%38.9%3674.531.51051002000
201597041.9%11.7%372100254100000
2016160047.7%41.0%402118451001100
2017151049.3%31.4%2316314661000100
2018151087.5%15.2%30167679140000100
2019160081.9%11.0%451373991500012131
2020132032.8%0.0%154320590000000
2021151023.2%2.7%15900722000100

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$915,000$1,500,000
Injury Adjusted$1,006,183$1,406,250
test
OTC Valuation $2.5M $5M $7.5M $10.1M $12.6M APY $3.3M $6.6M $9.9M $13.1M $16.4M $3,032,000 $2,433,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.